High-dose propofol drip for palliative sedation: A case report

American Journal of Hospice and Palliative Medicine

Volumn 25, Issue 6, 2009, Pages 492-495

  Herndon, Christopher M ^a   Zimmerman, Ethan ^a,b  

^a SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diprivan; Inpatient hospice; Propofol; Terminal agitation; Terminal restlessness

Indexed keywords

HYPNOTIC SEDATIVE AGENT; PROPOFOL;

ADDICTION; ARTICLE; BREAST TUMOR; CASE REPORT; COMMUNITY HOSPITAL; CONSCIOUS SEDATION; DRUG ADMINISTRATION; DRUG COST; DRUG MONITORING; ECONOMICS; FATALITY; FEMALE; HUMAN; INTRACTABLE PAIN; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; PAIN ASSESSMENT; PALLIATIVE THERAPY; PATIENT SELECTION; RESTLESSNESS; STATISTICS;

BREAST NEOPLASMS; CONSCIOUS SEDATION; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; DRUG MONITORING; FATAL OUTCOME; FEMALE; HOSPITALS, COMMUNITY; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; MIDDLE AGED; PAIN MEASUREMENT; PAIN, INTRACTABLE; PALLIATIVE CARE; PATIENT SELECTION; PROPOFOL; PSYCHOMOTOR AGITATION; SUBSTANCE-RELATED DISORDERS;

EID: 58149112803     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909108319268     Document Type: Article

References (9)

1. Weitzner MA, Moody LN, McMillan SC Symptom management issues in hospice care. Am J Hosp Palliat Care. 1997 ; 14: 190-195.
2. Braiteh F., El Osta B., Palmer JL, Reddy SK, Bruera E. Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center. J Palliat Med. 2007 ; 10: 948-955.
3. Hooke MC, Grund E., Quammen H., Miller B., McCormick P., Bostrom B. Propofol use in pediatric patients with severe cancer pain at the end of life. J Pediatr Oncol Nurs. 2007 ; 24: 29-34.
4. Lundstrom S., Zachrisson U., Furst CJ When nothing helps: propofol as sedative and antiemetic in palliative cancer care. J Pain Symptom Manage. 2005 ; 30: 570-577.
5. Levy MH, Cohen SD Sedation for the relief of refractory symptoms in the imminently dying: a fine intentional line. Semin Oncol. 2005 ; 32: 237-246.
6. Krakauer EL, Penson RT, Truog RD, King LA, Chabner BA, Lynch TJ Jr. Sedation for intractable distress of a dying patient: acute palliative care and the principle of double effect. Oncologist. 2000 ; 5: 53-62.
7. Jones MB Analgesia and continuous propofol infusion. J Pediatr Hematol Oncol. 1996 ; 18: 339.
8. Moyle J. The use of propofol in palliative medicine. J Pain Symptom Manage. 1995 ; 10: 643-646.
9. Mercadante S., De Conno F., Ripamonti C. Propofol in terminal care. J Pain Symptom Manage. 1995 ; 10: 639-642.